SciSparc

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SciSparc and other ETFs, options, and stocks.

About SPRC

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It operates through the Drug Development and Online Sales segments.

CEO

Oz Adler

CEOOz Adler

Employees

Employees2

Headquarters

Tel Aviv, Tel Aviv

HeadquartersTel Aviv, Tel Aviv

Founded

2004

Founded2004

Employees

Employees2

SPRC Key Statistics

Market cap

5.26M

Market cap5.26M

Price-Earnings ratio

-0.08

Price-Earnings ratio-0.08

Dividend yield

—

Dividend yield—

Average volume

314.08K

Average volume314.08K

High today

$3.57

High today$3.57

Low today

$3.24

Low today$3.24

Open price

$3.39

Open price$3.39

Volume

41.39K

Volume41.39K

52 Week high

$37.59

52 Week high$37.59

52 Week low

$1.75

52 Week low$1.75

SPRC News

TipRanks 4d

SciSparc’s Promising Clinical Study on SCI-210 for Autism Spectrum Disorder

SciSparc Ltd. ((SPRC)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Un...

TipRanks 4d

SciSparc Completes Acquisition of Neurothera Labs Inc.

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 7d

SciSparc closes acquisition of controlling interest in Neurothera Labs

SciSparc (SPRC)announced the closing of the transactions under the asset and share purchase agreement by and among the Company, Miza III Ventures and SciSparc N...

People also own

Based on the portfolios of people who own SPRC. This list is generated using Robinhood data, and it’s not a recommendation.